3rd edition Bioproduction of Immunotherapies
The 3rd edition of the Bioproduction of Immunotherapies co-organized by MabDesign and Medicen Paris Regon took place at Biocitech in Grand Paris the 18th September 2018.
Read moreSCIEX- new member
SCIEX has a longstanding track record in helping scientists in pharma discovery, development and manufacturing to transform pipeline capacity and capability through the adoption of CE and LC-MS technologies.
Read moreAIS2018 – The mAbs Event in France !
The 6th edition of the Antibody Industrial Symposium (AIS2018) co-organized by MabDesign and the LabEx MAbImprove took place at the Corum Conference Center in Montpellier from June 25th to June 26th 2018. The AIS2018 Congress gathered more than 250 participants from over 120 companies based in 11 different countries to discuss and learn about the latest innovations on Targets for MAbs and innovative approaches for their Discovery & Validation.
Read moreTALIX Therapeutics – new member
TALIX Therapeutics, is a privately-held biotech company pioneering the next generation of immune modulators with a diversified portofolio of first-in-class therapeutic antibodies in cancers.
Read moreGenoSafe – new member
GenoSafe® is a full contract research and consulting organization which specializes in evaluating the quality, safety and efficacy of innovative biological products.
Read more